Author

A. R. Shiakolas

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:human· 3 Assay:proteomics· 3 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Approach:deep learning· 1 Approach:machine learning (classical)· 1

Frequent Co-Authors

I. S. Georgiev· 4 shared J. E. Crowe· 4 shared K. J. Kramer· 4 shared N. Raju· 4 shared N. Suryadevara· 4 shared R. H. Carnahan· 4 shared D. Wrapp· 3 shared J. S. McLellan· 3 shared

Activity by Year

2020-2021 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersImmunology

I. S. Georgiev

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

ImmunologybioRxivJul 28, 2021

Single-Cell Profiling of the Antigen-Specific Response to BNT162b2 SARS-CoV-2 RNA Vaccine

K. J. Kramer, E. M. Wilfong, K. Voss…·J. M. Irish

DOI 10.1038/s41467-022-31142-5

𝕏 PostBluesky

ImmunologybioRxivPreprintJun 2, 2021

Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking

A. R. Shiakolas, N. Johnson, K. J. Kramer…·I. S. Georgiev

This study demonstrates that integrating ligand blocking into LIBRA-seq improves the efficiency of identifying potent SARS-CoV-2 neutralizing antibodies.

DOI 10.1101/2021.06.02.446813

experimental assayhost-pathogen & immune response

𝕏 PostBluesky

ImmunologybioRxivMay 16, 2021

Potent neutralization of SARS-CoV-2 variants of concern by an antibody with a unique genetic signature and structural mode of spike recognition

K. J. Kramer, N. V. Johnson, A. R. Shiakolas…·I. S. Georgiev

This study identifies a potent SARS-CoV-2 antibody, 54042-4, that neutralizes variants of concern and has a unique epitope and genetic structure.

DOI 10.1016/j.celrep.2021.109784

humanproteomics

𝕏 PostBluesky

ImmunologybioRxivPreprintDec 20, 2020

Cross-reactive coronavirus antibodies with diverse epitope specificities and extra-neutralization functions

A. R. Shiakolas, K. J. Kramer, D. Wrapp…·I. S. Georgiev

The paper identifies cross-reactive antibodies against multiple coronaviruses, showing they target diverse epitopes and mediate effector functions.

DOI 10.1101/2020.12.20.414748

humanproteomics

𝕏 PostBluesky